RA CAPITAL MANAGEMENT, L.P. - Director at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
MLYS on Nasdaq
All Insider Reports
All Insider Reports

RA CAPITAL MANAGEMENT, L.P. - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by RA CAPITAL MANAGEMENT, L.P. for Mineralys Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6,200 $212,536 $34.28 19 Feb 2026 Indirect
Stock Option (Right to Buy) 8,300 19 Feb 2026 Indirect Common Stock

Transactions reported by RA CAPITAL MANAGEMENT, L.P. for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.